VCID CWOW: Identifying Novel Targets to Treat Cerebral Amyloid Angiopathy — Gareth R Howell (JACKSON LABORATORY)
Alzheimer’s disease (AD), most common form of dementia, affects over 55 million people worldwide. Numbers are expected to double every 20 years unless improved treatments are developed. AD is characte
| Project title | VCID CWOW: Identifying Novel Targets to Treat Cerebral Amyloid Angiopathy |
|---|---|
| Project number | 1RF1NS139948-01 |
| PI name | Gareth R Howell |
| Institution | JACKSON LABORATORY |
| Funding mechanism | RF1 |
| Agency | NINDS |
| Award amount | $5.95M |
| Fiscal year | 2024 |
| Project start | 2024-09-18T00:00:00 |
| Project end | 2027-08-31T00:00:00 |
| Abstract | Alzheimer’s disease (AD), most common form of dementia, affects over 55 million people worldwide. Numbers are expected to double every 20 years unless improved treatments are developed. AD is characte |
| Key terms | <AD dementia><AD pathology><AD related dementia><ADRD><APOE e4><APOE-ε4><APOEε4><Acceleration><Adven |
$799/mo
Try GrantRadar →